Type 2 diabetes (T2DM) and its complications constitute a major worldwide public health
problem, with high rates of morbidity and mortality. Biomarkers for predicting the occurrence …

Oxidant–antioxidant imbalance is involved in the etiology of different diseases, including
cardiovascular diseases (CVDs), liver disorders, kidney diseases, cancers and diabetes …

A direct and an indirect relationship between paraoxonase 1 (PON1) and atherosclerosis
exists. Given PON1's physical location within high‐density lipoprotein (HDL) particles and its …

The protein composition of high‐density lipoprotein (HDL) is extremely fluid. The quantity
and quality of protein constituents drive the multiple biological functions of these …

Abstract Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disease with symptoms that
go beyond the domain of glucose metabolism. In fact, research has shown that T2DM is …

Lipoprotein‐associated phospholipase A2 (Lp‐PLA2) is a new specific vascular
inflammation biomarker that is carried by the lipoproteins in the blood and plays a prominent …

Paraoxonase 1 (PON1) is a high-density lipoprotein (HDL)-associated protein that endows
its carrier with (lipo-) lactonase-dependent antioxidative features. Low levels of PON1 …

A wealth of evidence suggests that Lipoprotein-associated phospholipase A2 (Lp-PLA2)
plays a relevant role in atherogenesis and inflammation, which in turn are associated with …

Functional assessment of cholesterol efflux capacity (CEC) to high-density lipoprotein (HDL)
is an emerging tool for evaluating morbidity and mortality associated with cardiovascular …

Background: Paraoxonase1 (PON1), an enzyme connected to high density lipoproteins
(HDL) particles, plays an important role in protecting arteries against atherosclerosis. The …